Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
Recent studies are dramatically expanding our understanding of how diseases originate and evolve, using advanced genomic analysis and large-scale population data to trace disease roots back through history and across the globe. Scientists have discovered that diseases don’t emerge randomly—they follow predictable evolutionary patterns shaped by ancient human migration, animal populations, and the biological struggles between pathogens and the viruses that attack them. A groundbreaking genomic study of heartworm parasites, for example, revealed that canine heartworm populations followed the same migration routes as ancient humans and their dogs, suggesting that understanding disease origins requires examining the deep historical relationships between humans, animals, and infectious agents.
These discoveries matter because they help researchers understand why certain diseases develop the way they do, how they spread geographically, and what trade-offs pathogens make that could eventually lead to their weakness. By analyzing the complete genomes of parasites like heartworm from populations worldwide, scientists are uncovering patterns that had been invisible for decades. The expansion of massive population biobanks—databases containing genetic material, imaging data, and lifelong health records from millions of diverse individuals—is now making it possible to study disease origins at a scale never before possible.
Table of Contents
- How Genomics Is Revealing the Ancient Origins of Modern Diseases
- The Hidden Trade-Offs in Pathogen Evolution
- Population-Level Data Revolutionizing Disease Origin Research
- Developmental Origins Shape Lifelong Disease Risk
- Gaps in Our Knowledge and the Limitations of Current Research
- Brain Health and Neurodegenerative Disease Origins
- The Future of Disease Origins Research
- Conclusion
How Genomics Is Revealing the Ancient Origins of Modern Diseases
The first complete genome sequences of the heartworm parasite (*Dirofilaria immitis*) from populations around the world have provided unprecedented insights into how this disease evolved alongside humans and animals. researchers from the University of Sydney and the Wellcome Sanger Institute analyzed these genomes and discovered something striking: the heartworm populations mirrored the migration patterns of ancient canids and the humans who lived alongside them. This wasn’t a coincidence—it was evidence of co-evolution spanning thousands of years. The findings represent the first comparative analysis of heartworm genomes across global populations, opening a new window into understanding how parasitic diseases become established in different regions and why certain populations are more vulnerable than others.
What makes this research particularly important is that it demonstrates diseases don’t have uniform origins worldwide. Instead, different populations of the same parasite evolved distinct characteristics based on their local hosts and environments. By understanding these evolutionary pathways, veterinarians and public health officials can better predict where heartworm will be most problematic, which treatment approaches might be most effective, and how the disease is likely to change in the future. The comparison between different heartworm populations is similar to how different human populations show variations in disease susceptibility—understanding the “why” behind those variations requires looking at evolutionary history, not just current symptoms.
The Hidden Trade-Offs in Pathogen Evolution
A 20-year longitudinal genomic study of cholera bacteria revealed a surprising mechanism of disease that has profound implications for how we think about infection: bacteria that maintain strong antiviral defenses cause less severe illness in humans, but they’re also less likely to spread beyond their region of origin. This discovery illuminates a fundamental evolutionary trade-off. The cholera bacteria must choose, in effect, between investing resources in defending themselves against the viruses that infect them or in virulence—their ability to cause severe disease that might facilitate human-to-human transmission. Bacteria that prioritize antiviral defenses are protecting themselves, but at the cost of transmissibility.
This limitation is crucial to understand: bacteria don’t make conscious choices, but evolution shapes which strains persist based on their success in spreading. A strain that causes milder disease might survive longer in an individual host and persist in a population, but it won’t spread as efficiently as a more virulent strain. This creates a dynamic evolutionary struggle, constantly shifting as viruses attack bacteria, bacteria evolve defenses, and the balance determines which populations expand and which decline. The research demonstrates that disease severity isn’t random or predetermined—it emerges from these underlying biological conflicts and trade-offs. For public health planning, this means understanding a disease’s evolutionary history can actually help predict whether it will become more or less severe over time.
Population-Level Data Revolutionizing Disease Origin Research
The expansion of longitudinal biobanks represents a fundamental shift in how scientists study disease origins. Major initiatives like the UK Biobank, the All of Us Research Program in the United States, and FinnGen in Finland have collected biospecimens, imaging data, genomic information, and comprehensive health records from millions of diverse individuals. These databases span decades of health information, capturing disease trajectories from their earliest stages through progression or recovery. Rather than studying diseases in isolated snapshots, researchers can now observe how diseases develop over a person’s lifetime and across entire populations.
This population-level approach has already transformed disease research. For example, scientists using these biobanks can now identify which genetic variations increase disease risk, which environmental factors modify that risk, and how different populations experience different disease trajectories for the same condition. The diversity in these databases is essential—a disease that manifests one way in a Northern European population might present differently in an African or Asian population due to genetic variation, environmental factors, and lifestyle differences. By studying disease origins at this scale and diversity level, researchers are moving beyond one-size-fits-all understanding toward more nuanced, population-specific knowledge that can inform prevention and treatment strategies.
Developmental Origins Shape Lifelong Disease Risk
Understanding disease origins isn’t just about tracing pathogens backward through evolutionary time—it’s also about understanding how diseases begin during human development. Research supported by the National Institute of Environmental Health Sciences focuses on the developmental origins of health and disease, examining how conditions in the womb and during early childhood shape disease risk throughout life. This framework suggests that many chronic diseases don’t suddenly appear in adulthood; instead, their seeds are planted during critical developmental windows when organs and systems are forming. The comparison between infectious disease origins and developmental disease origins reveals complementary truths.
While heartworm evolved alongside ancient human populations, conditions like cardiovascular disease and metabolic disorders are being shaped during fetal development and infancy. A nutritional deficiency during pregnancy, exposure to environmental toxins, or early-life stress can alter how a child’s organs develop, setting the stage for disease decades later. This means preventing disease requires intervention at multiple stages—some diseases need control of their pathogenic sources (like parasites), while others need attention to early-life environments and developmental support. The combination of evolutionary genomics and developmental biology is creating a more complete picture of why people get sick and when interventions might be most effective.
Gaps in Our Knowledge and the Limitations of Current Research
Despite these advances, significant limitations remain in our understanding of disease origins. Genomic studies of pathogens like heartworm represent a major breakthrough, but they’re still limited to analyzing the organisms themselves—they don’t directly explain why certain humans or animals are more susceptible to infection in the first place. The genetic variation within host populations (both human and animal) is enormous, and predicting individual susceptibility based on pathogen evolution alone isn’t possible. Additionally, most large biobanks are geographically and ethnically biased, concentrated in wealthy nations and among populations of European ancestry, which means our understanding of disease origins is incomplete for much of the world’s population.
Another critical limitation is that genomic and biobank research capture current and recent patterns but may not fully explain origins going back centuries or millennia. The heartworm study is remarkable, but it relied on fossilized and modern DNA; for many diseases, such ancient genetic material simply doesn’t exist. Furthermore, the interaction between multiple diseases, environmental factors, and genetic backgrounds creates complexity that current research methods struggle to untangle. When studying disease origins in populations, researchers often can’t determine whether a genetic variant increases disease risk, whether it’s a marker for some other genetic factor, or whether it’s an environmental variable entirely that’s being mistaken for genetics.
Brain Health and Neurodegenerative Disease Origins
For those concerned with dementia and brain health, understanding disease origins has particular relevance. Many neurodegenerative conditions likely have their roots in developmental factors, genetic predisposition, environmental exposures, and potentially infectious agents—all of which are areas where the expanded research into disease origins is making discoveries. Studies examining the developmental origins of neurological health suggest that factors affecting the brain during critical periods of development may increase vulnerability to conditions like Alzheimer’s disease or Parkinson’s disease decades later.
The same population biobanks that are revealing disease origins for infectious and metabolic conditions are now being analyzed for patterns predicting neurodegeneration. Emerging research is also investigating whether certain infections might play a role in neurodegenerative disease origins—a hypothesis that parallels the understanding that some cancers originate from chronic viral infections. While no pathogen has been definitively shown to cause Alzheimer’s disease, researchers are examining whether bacterial infections, viral infections, or parasitic exposures contribute to the neuroinflammation that characterizes many brain diseases. The tools and frameworks developed for understanding heartworm origins and cholera evolution are now being applied to understand what initiates the cascade of changes leading to dementia.
The Future of Disease Origins Research
As genomic sequencing becomes faster and cheaper, and as biobanks continue to expand globally, the future of disease origins research will likely shift toward more integrated, multi-level understanding. Researchers will be able to simultaneously examine evolutionary history of pathogens, genetic variation in host populations, developmental exposures, environmental factors, and lifestyle influences as they shape disease across entire populations and across generations. The next decade will likely see major advances in understanding not just where diseases come from, but why some populations are affected more severely than others and what interventions might prevent disease before it develops.
The convergence of infectious disease genomics, developmental biology, and population genetics suggests that future disease prevention will be far more targeted and personalized than current approaches. Rather than treating all heartworm infections the same or assuming all cholera outbreaks follow the same pattern, medicine will increasingly account for regional evolutionary variation and individual developmental history. For dementia and other chronic diseases affecting aging populations, understanding origins will shift focus toward prevention in young and middle-aged adults—identifying and modifying the developmental and environmental factors that determine who develops disease later in life.
Conclusion
Recent studies are revealing that diseases have comprehensible origins that can be traced through evolutionary history, genetic analysis, and population-level data. The genomic study of heartworm parasites showed how pathogens evolve alongside human and animal populations, while cholera research illuminated the biological trade-offs that shape disease severity and transmissibility. Massive population biobanks are making it possible to study disease origins at an unprecedented scale, tracking how conditions develop across decades and diverse populations.
These advances matter because understanding where diseases come from—whether from ancient pathogens or early-life developmental factors—enables more targeted prevention and treatment. The expanding understanding of disease origins has immediate practical implications for dementia care and brain health. By applying the same genomic and population-level research approaches to neurodegenerative diseases, scientists are beginning to identify the factors that initiate disease processes decades before symptoms appear. This shift from understanding disease origins to preventing disease before it develops represents the future of medicine—one where intervention happens at the root, based on knowledge of how and why diseases originate in the first place.
